Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: NYU Ovarian Cancer Early Detection Program Blood and Genetics
The NYU ovarian cancer early detection program blood and genetics clinical trial has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-01-10Clinical Trial Update: Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer [Phase 2]
This document reports the Phase 2 results of a chemoimmunotherapy study in epithelial ovarian cancer. The trial status is completed and resu…
-
CLINICAL_TRIALS trial_result · 2011-01-10Clinical Trial Update: Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors [Phase 2]
Phase 2 trial evaluating amifostine followed by high-dose chemotherapy in patients with hematologic cancers and solid tumors; the study stat…
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer [Phase 2]
Phase II open-label trial evaluating GW786034 in ovarian cancer and peritoneal cancer; study completed with results posted in 2011.
-
CLINICAL_TRIALS research · 2011-01-04Clinical Trial Update: Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis
A clinical trial update discusses research on circulating lymphatic progenitor cells and lymph node metastasis. The study concerns ovarian c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-12-22Clinical Trial Update: Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer [Phase 3]
Phase 3 trial evaluated pyridoxine (vitamin B6) in preventing hand-foot syndrome in patients treated with liposomal doxorubicin for several …
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab plus erlotinib in advanced ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS research · 2010-12-13Clinical Trial Update: Retrospective Study of Ovarian Cancer Patients With Brain Metastasis
An update on a retrospective study of ovarian cancer patients with brain metastases, sponsored by National Taiwan University Hospital.
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors [Phase 2]
Phase 2 feasibility study evaluating pazopanib in combination with chemotherapy for gynecologic tumors; the trial has completed and results …
-
FDA approval · 2010-12-02FDA Approved: TOPOTECAN HYDROCHLORIDE — Original Application (Actavis Pharma, Inc.)
FDA approved the original application for Topotecan Hydrochloride from Actavis Pharma, Inc. as a generic cancer therapy.
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of bevacizumab with carboplatin and paclitaxel in ovarian, fallopian tube, or primary peritoneal cancer; the study was termina…
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Letrozole in Patients With Ovarian Tumors [Phase 2]
Phase 2 trial of letrozole in patients with ovarian tumors (ovarian, fallopian tube, and peritoneal cancer) was terminated with results post…
-
CLINICAL_TRIALS research · 2010-10-11Clinical Trial Update: Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk
The MSKCC-sponsored clinical trial assessing awareness and attitudes toward prenatal and preimplantation genetic diagnosis for inherited bre…
-
CLINICAL_TRIALS trial_result · 2010-10-08Clinical Trial Update: A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer [Phase 4]
Phase 4 clinical trial comparing primary prophylaxis with Neulasta (pegfilgrastim) to secondary prophylaxis after chemotherapy in elderly ca…
-
CLINICAL_TRIALS trial_result · 2010-10-04Clinical Trial Update: Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer [Phase 2]
This update reports that a Phase 2 trial of ispinesib in platinum-taxane-refractory or resistant relapsed ovarian cancer has completed. Spon…
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 trial of chemotherapy followed by bone marrow or stem cell transplantation for relapsed or refractory germ cell tumors, in…
-
CLINICAL_TRIALS trial_result · 2010-09-23Clinical Trial Update: Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma
This entry documents the completion of a clinical trial evaluating microvascular ultrasonographic imaging for detecting early-stage epitheli…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating the combination of docetaxel and carboplatin in relapsed stage III/IV ovarian epithelial cancer or primary peritone…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated the three-drug combination of erlotinib, docetaxel, and carboplatin in newly diagnosed Stage III or Stage IV ova…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial of gemcitabine and topotecan in recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients [NA]
A completed clinical trial update examining the emotional needs of caregivers of stem cell transplantation patients is reported.
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating allogeneic natural killer cells in patients with recurrent ovarian, Fallopian tube, and primary peritoneal cancers;…
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission [Phase 1]
Phase 1 study evaluating a conditioning regimen of melphalan and thiotepa followed by peripheral stem cell transplantation in patients with …
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating chemotherapy followed by peripheral stem cell transplantation for persistent or platinum-refractory stage …
-
CLINICAL_TRIALS trial_result · 2010-09-09Clinical Trial Update: An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy [Phase 3]
Phase 3 trial in ovarian, primary peritoneal, or fallopian tube cancer has completed with results posted.